Latest Krensavage Asset Management, LLC Stock Portfolio
$263Million | No. of Holdings #18
Krensavage Asset Management, LLC Performance
2026 Q2+3.60%
YTD+3.61%
2025+55.92%
About Krensavage Asset Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Krensavage Asset Management, LLC reported an equity portfolio of $263.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Krensavage Asset Management, LLC are ENTA, JAZZ, UTHR. The fund has invested 15.9% of it's portfolio in ENANTA PHARMACEUTICALS INC and 15.4% of portfolio in JAZZ PHARMACEUTICALS PLC. <br><br> The fund managers got completely rid off INDIVIOR PHARMACEUTICALS INC and ALKERMES PLC (ALKS) stocks. They significantly reduced their stock positions in UNITED THERAPEUTICS CORP (UTHR) and EXELIXIS INC (EXEL). The fund showed a lot of confidence in some stocks as they added substantially to ABBOTT LABORATORIES (ABT), EMBECTA CORP (EMBC) and REGENERON PHARMACEUTICALS (REGN).
Krensavage Asset Management, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$263Million
as of Aug 14, 2026Krensavage Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Krensavage Asset Management, LLC made a return of 3.6% in the last quarter. In trailing 12 months, it's portfolio return was 47.34%.
- Performance
- S&P 500
New Buys
No new stocks were added by Krensavage Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| abbott laboratories | 3,900 |
| embecta corp | 54.4 |
| regeneron pharmaceuticals | 50.00 |
| ardelyx inc | 6.9 |
Additions to existing portfolio by Krensavage Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| united therapeutics corp | -17.8 |
| exelixis inc | -10.83 |
Krensavage Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| indivior pharmaceuticals inc | -10,349,000 |
| alkermes plc | -3,813,000 |
Krensavage Asset Management, LLC got rid off the above stocks
Sector Distribution
Krensavage Asset Management, LLC has about 90% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 90 |
| Others | 10 |
Market Cap. Distribution
Krensavage Asset Management, LLC has about 58.7% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- SMALL-CAP
- UNALLOCATED
- MID-CAP
- MICRO-CAP
| Category | % |
|---|---|
| LARGE-CAP | 58.7 |
| SMALL-CAP | 20.1 |
| UNALLOCATED | 10 |
| MID-CAP | 9.9 |
| MICRO-CAP | 1.4 |
Stocks belong to which Index?
About 37.1% of the stocks held by Krensavage Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 62.9 |
| RUSSELL 2000 | 27.1 |
| S&P 500 | 10 |
Krensavage Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Krensavage Asset Management, LLC
Krensavage Asset Management, LLC has 18 stocks in it's portfolio. About 89.4% of the portfolio is in top 10 stocks. EMBC proved to be the most loss making stock for the portfolio. JAZZ was the most profitable stock for Krensavage Asset Management, LLC last quarter.
$263.22MTotal Value
20.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Abbott Laboratories Krensavage Asset Management, LLC's holding in Abbott Laboratories over time | 6.89% | 200,000 | $18.15M 6.89% | 3900%increased 3900 percentadded | |
 Alkermes Plc Alkermes PlcALKS Krensavage Asset Management, LLC's holding in Alkermes Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Ardelyx Inc Ardelyx IncARDX Krensavage Asset Management, LLC's holding in Ardelyx Inc over time | 1.04% | 534,523 | $2.73M 1.04% | 6.9%increased 6.9 percentadded | |
 Biogen Inc Biogen IncBIIB Krensavage Asset Management, LLC's holding in Biogen Inc over time | 1.64% | 20,000 | $4.32M 1.64% | 0%unchanged 0 percentunchanged | |
 Biomarin Pharmaceutical Inc Krensavage Asset Management, LLC's holding in Biomarin Pharmaceutical Inc over time | 11.41% | 524,786 | $30.03M 11.41% | 0%unchanged 0 percentunchanged | |
 BNTX Biontech Se-AdrBiontech Se-AdrBNTX | 2.1% | 59,523 | $5.54M 2.1% | 0%unchanged 0 percentunchanged | |
 Embecta Corp Embecta CorpEMBC Krensavage Asset Management, LLC's holding in Embecta Corp over time | 1.41% | 1,135,340 | $3.70M 1.41% | 54.4%increased 54.4 percentadded | |
 Enanta Pharmaceuticals Inc Krensavage Asset Management, LLC's holding in Enanta Pharmaceuticals Inc over time | 15.88% | 2,866,140 | $41.79M 15.88% | 0%unchanged 0 percentunchanged | |
 Evolus Inc Evolus IncEOLS Krensavage Asset Management, LLC's holding in Evolus Inc over time | 0.42% | 157,985 | $1.10M 0.42% | 0%unchanged 0 percentunchanged | |
 Exelixis Inc Exelixis IncEXEL Krensavage Asset Management, LLC's holding in Exelixis Inc over time | 7.66% | 370,693 | $20.17M 7.66% | 10.83%decreased 10.83 percentreduced | |
 GSK Gsk Plc-Spon AdrGsk Plc-Spon AdrGSK | 1.93% | 96,729 | $5.07M 1.93% | 0%unchanged 0 percentunchanged | |
 INMD Inmode LtdInmode LtdINMD | 0.67% | 120,942 | $1.77M 0.67% | 0%unchanged 0 percentunchanged | |
 Jazz Pharmaceuticals Plc Krensavage Asset Management, LLC's holding in Jazz Pharmaceuticals Plc over time | 15.36% | 167,816 | $40.44M 15.36% | 0%unchanged 0 percentunchanged | |
 Ultragenyx Pharmaceutical In Krensavage Asset Management, LLC's holding in Ultragenyx Pharmaceutical In over time | 4.96% | 390,879 | $13.05M 4.96% | 0%unchanged 0 percentunchanged | |
 Regeneron Pharmaceuticals Krensavage Asset Management, LLC's holding in Regeneron Pharmaceuticals over time | 1.42% | 6,000 | $3.74M 1.42% | 50%increased 50 percentadded | |
 SNY Sanofi-AdrSanofi-AdrSNY | 5.25% | 323,946 | $13.82M 5.25% | 0%unchanged 0 percentunchanged | |
 Supernus Pharmaceuticals Inc Krensavage Asset Management, LLC's holding in Supernus Pharmaceuticals Inc over time | 4.96% | 280,681 | $13.05M 4.96% | 0%unchanged 0 percentunchanged | |
 United Therapeutics Corp Krensavage Asset Management, LLC's holding in United Therapeutics Corp over time | 14.26% | 69,282 | $37.54M 14.26% | 17.8%decreased 17.8 percentreduced | |
 Vanda Pharmaceuticals Inc Krensavage Asset Management, LLC's holding in Vanda Pharmaceuticals Inc over time | 2.74% | 1,180,390 | $7.22M 2.74% | 0%unchanged 0 percentunchanged | |
Com Indivior Pharmaceuticals IncIndivior Pharmaceuticals Inc | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |